What Teladoc Health Bulls Got Right

Die Übersetzung ist noch nicht verfügbar. Der Originalartikel wird angezeigt.

Teladoc Health spent the past year juggling a Walmart virtual care rollout, an expanding AI toolset like SoloVitals and SoloScribe, and a sharp reset in BetterHelp's cash-pay demand that even drew securities law firms into the story. For Teladoc Health shareholders, the return over the past year was 23.5%, including dividends. If you were deciding whether to buy on 5 November 2025, what exactly would you have needed to believe about chronic care, BetterHelp and legal risk to hold through all that? A Narrative on Simply Wall St is one investor's written case for a company, with its growth, margin and multiple assumptions spelled out. Those assumptions imply an estimated Fair Value. Teladoc Health is not the only name tied to this theme.